Borderline Personality Disorder
Conditions
Interventions
None listed
Sponsors
Nippon Boehringer Ingelheim Co., Ltd. (NBI: Sponsor)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who have medical records of the first visit at psychiatry department of the study site, on or after January 1st, 2013 2)Patients with records of BPD diagnosed using DSM-5, ICD-10, DSM-IV-TR or clinically evaluated by experienced physicians who are working as psychiatrists in Japan 3)Patients who have provided informed consent of their own free will (by research subjects, etc. [research subjects or their legally acceptable representatives, etc.) in writing or orally after receiving sufficient explanation from the investigator, etc. and understanding the content. (If it is difficult to obtain informed consent from research subjects, etc., appropriate consent must be obtained. If it is difficult to obtain appropriate consent because the valid contact information is not available due to relocation or other reasons, or obtaining informed consent from research subjects, etc. may interfere with the execution of this study considering the time available and cost, etc. to obtain consent, opt-out enrollment will be permitted.)
Exclusion criteria
Exclusion criteria: 1)Patients with BPD who see the physicians planning this study, including Boehringer Ingelheim Co., Ltd. Employees, the members of the steering committee and advisors 2)Patients who had participated in research studies involving interventions during the target period of data collection 3)Patients judged to be inappropriate by the principal investigator or sub-investigator for some reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of treatment by treatment type for patients with BPD | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients with core symptoms of BPD at the first visit at the study sites Proportion of types of core symptoms in patients with BPD at the time of BPD diagnosis at the study sites Period from the first visit to BPD diagnosis Proportion of patients with psychiatric disorders after BPD diagnosis Proportion of patients using medical resource after BPD diagnosis and types of medical resource Proportion of patients using social resource after BPD diagnosis and types of social resource Proportion of family members (genetically related 1st to 4th degree relatives) with psychiatric disorders that became apparent before and after the patient's BPD diagnosis Proportion of patients showing improvement, exacerbation, and unchanging of symptoms Proportion of patients with BPD who have gone into remission Proportion of patients who achieved social reintegration after BPD diagnosis Proportion of patients with BPD relapse to patients with BPD who have gone into remission Proportion of patients with BPD who have attempted suicide Proportion of patients who have discontinued treatment due to patient's circumstances Patient background | — |
Countries
Japan
Contacts
Public ContactTaketo Kimura
Mebix, Inc. Clinical Operations
Outcome results
None listed